The UF Health Proton Therapy Institute enhanced its playroom, a respite for its pediatric patients, significantly with innovative technology that promotes therapeutic engagement, with an 86” interactive gaming wall that features educational and sensory software.
Researchers from the University of Southern California found a genetic variant contributing to disparities in childhood leukemia risk. The variant, located on the IKZF1 gene, helps explain why Hispanic/Latino children face a higher risk of acute lymphoblastic leukemia and offers insights about what causes the disease.
Joshua Cohn, associate professor in the Department of Urology at Fox Chase Cancer Center and a member of the Fox Chase – Temple Urologic Institute, was named a consultant at Shriners Children’s Philadelphia.
The largest clinical trial to date seeking to reduce the risk of people who have survived childhood cancer from developing heart failure found that carvedilol, a blood vessel relaxing medication, is safe for childhood cancer survivors and may improve important markers of heart injury sustained as a result of chemotherapy exposure.
Debra Friedman, E. Bronson Ingram Chair in Pediatric Oncology, was named deputy director of Vanderbilt-Ingram Cancer Center.
Alanna Joyce Church has received the The American Association for Cancer Research-St. Baldrick’s Foundation Pediatric Cancer Research Grant, a one-year, $75,000 award recognizing junior-level faculty members who have demonstrated promise for continued substantive contributions to pediatric cancer research.
About 12 children with cancer or other blood disorders have been evacuated, with their companions, from the Gaza Strip in the occupied Palestinian territory to Egypt and Jordan so they may continue their treatment safely. Additional children are expected to be evacuated for cancer treatment as part of this initiative.
Anthony Faber, a professor in the Philips Institute for Oral Health Research at the Virginia Commonwealth University School of Dentistry and Massey Comprehensive Cancer Center, has received four grants totaling more than $6.3 million to aid in the development of new targeted therapies for neuroblastoma and synovial sarcoma.
Rady Children’s oncologist Paula Aristizabal receives $4M to diversify clinical trials participation
Paula Aristizabal, a pediatric oncologist at Rady Children’s Hospital-San Diego and associate professor of pediatrics in pediatric hematology/oncology at the University of California San Diego and Moores Cancer Center, received a $4 million R01 research grant to expand a pilot program aimed at improving diverse participation in pediatric cancer clinical trials.
Purdue University renamed its pediatric cancer research center the Tyler Trent Pediatric Cancer Research Center within the Purdue Institute for Cancer Research.
